ESC Clinical Practice Guidelines on Cardio-Oncology:

troponin) it is working Cardiac magnetic resonance Cardiac computed tomography checks the function and provides a detailed picture of structure of the heart your heart and blood vessels • If your cancer treatment has the potential to cause cardiotoxicity and you are considered at low risk, then you may just need one or two tests during treatment and one follow-up heart check in the first year after completing your treatment. • If your cancer treatment has the potential to cause cardiotoxicity and you are considered at moderate risk, then you will need closer monitoring of your heart health with more frequent tests during and after treatment. • If your cancer treatment has the potential to cause cardiotoxicity and you are considered at high risk then you will need to see a cardiologist before starting treatment, and you may require heart medication (called “cardio-protection”) during your cancer therapy. The ESC Guidelines provide information to your oncologist/ haematologist and your cardiologist on which heart medication to consider and which tests to carry out during cancer treatment and in the first year after treatment. Commonly Asked Questions Before Cancer Treatment Remember, you can ask your medical team if there is anything you would
